Founded in 2006 by the UCSF Department of Orthopedic Surgery faculty and residents, the Institute for Global Orthopaedics and Traumatology, or IGOT, is celebrating 15 years of addressing global disparities in orthopaedic trauma care. This video highlights IGOT's incredible team and the programs that are dramatically changing surgical outcomes. Validating IGOT's global impact, the Wyss Medical Foundation - a long-time supporter of IGOT - renewed its commitment to our organization in 2021 with a five-year grant. To help support our mission or to learn more please click on igotglobal.org. Series: "The Institute for Global Orthopaedics and Traumatology " [Health and Medicine] [Education] [Show ID: 37736]

As the second anniversary of the start of the COVID-19 pandemic approaches, along with the specter of outbreaks during the winter season, the world continues to grapple with uncertainties of the pandemic. Join UC San Diego experts who describe how epidemic modeling and data-driven approaches led to the strategies behind UC San Diego’s Return to Learn program. Scientists also discuss the latest research on proteins known as interferons and their promise as anti-viral COVID-19 therapeutics. And finally, hear from evolutionary biologists about what we’ve learned about disease transmission, changes from the initial Wuhan virus strain and what these variants could mean for the future of this pandemic. Series: "A Deep Look into the Future of Biology" [Health and Medicine] [Science] [Education] [Show ID: 37692]

Dr. Elisseeff is a leading expert in the field of tissue engineering. She directs the Translational Tissue Engineering Center where she and her team of scientists study stem cells, develop new biomaterials, and design new technologies for regenerative medicine. The goal of her lab is to engineer technologies to repair lost tissues. Specifically, Elisseeff's lab examines hydrogels as a scaffold for tissue engineering. Hydrogels are ideal due to their high water content for nutrient and waste transport, and their ability to encapsulate cells and to implant in a minimally invasive manner. The lab is currently focused on developing synthetic-biological hydrogels with highly controlled physical properties and biological function. The discovery of human embryonic stem cells has created the possibility to regenerate any tissue from a single, totipotent cell population. Series: "Stem Cell Channel" [Health and Medicine] [Science] [Education] [Show ID: 37017]

Joseph Sullivan, MD, Professor of Neurology and of Pediatrics; UCSF Weill Institute for Neurosciences, University of California San Francisco; Director of the UCSF Pediatric Epilepsy Center; Benioff Children’s Hospital, San Francisco. Series: "Developmental Disabilities Update" [Education] [Show ID: 36981]

Diane E. J. Stafford, MD, Clinical Professor of Pediatrics; Associate Chief, Division of Endocrinology and Diabetes; Associate Program Director, Pediatric Endocrinology Fellowship; Stanford University School of Medicine. Series: "Developmental Disabilities Update" [Education] [Show ID: 36979]

Sheraden Nicholau, Regional Manager, Bay Area State Council on Developmental Disabilities. Series: "Developmental Disabilities Update" [Education] [Show ID: 36963]

Noemi A. Spinazzi, MD, FAAP. Assistant Clinical Professor of Pediatrics; Medical Director, Down Syndrome Clinic, UCSF Benioff Children's Hospital, Oakland. Series: "Autism Awareness Programs" [Education] [Show ID: 36968]

Christine Wu Nordahl, PhD, Associate Professor of Psychiatry and Behavioral Sciences, UC Davis MIND Institute. Series: "Autism Awareness Programs" [Education] [Show ID: 36977]

Dolores Tejada, Lead Organizer, East Bay Housing Organizations Series: "Developmental Disabilities Update" [Education] [Show ID: 36962]

Randi J. Hagerman, MD, FAAP. Distinguished Professor of Pediatrics; Director of the Fragile X Research and Treatment Center; UC Davis MIND Institute. Series: "Developmental Disabilities Update" [Education] [Show ID: 36978]